🚨 JUST IN: Parataxis Buys Korean Biotech Firm to Launch Bitcoin Treasury Vehicle
🇰🇷 Parataxis Holdings has acquired Bridge Biotherapeutics for $18.5 million, with plans to convert it into an institutionally backed Bitcoin treasury platform listed on South Korea’s public markets.
The move reflects a growing trend of using public companies as vehicles for crypto asset exposure.
💬 Could this mark the beginning of more biotech-to-Bitcoin transitions in global markets?